跳转至内容
Merck
CN
  • Development of 2,4-diaminopyrimidine derivatives as novel SNSR4 antagonists.

Development of 2,4-diaminopyrimidine derivatives as novel SNSR4 antagonists.

Bioorganic & medicinal chemistry letters (2011-02-22)
Malken Bayrakdarian, Joanne Butterworth, Yun-Jin Hu, Vijayaratnam Santhakumar, Mirosław J Tomaszewski
摘要

2,4-Diaminopyrimidines derivatives were developed as a novel class of SNSR4 antagonists. Structure activity relationship of the diamino pyrimidine core was explored and a tool compound suitable for target validation was identified.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
2,4-二氨基嘧啶, 98%